Product Images Cinacalcet

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Cinacalcet NDC 16729-442 by Accord Healthcare, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Mean (SE) iPTH Values (Pooled Phase 3 Studies) - cinacalcet 01

Figure 1. Mean (SE) iPTH Values (Pooled Phase 3 Studies) - cinacalcet 01

Not available.*

Figure 2. Mean (SE) Ca x P Values (Pooled Phase 3 Studies) - cinacalcet 02

Figure 2. Mean (SE) Ca x P Values (Pooled Phase 3 Studies) - cinacalcet 02

Figure 3. Serum Calcium Values in Patients With Parathyroid Carcinoma Receiving Sensipar at Baseline, Titration, and Maintenance Phase - cinacalcet 03

Figure 3. Serum Calcium Values in Patients With Parathyroid Carcinoma Receiving Sensipar at Baseline, Titration, and Maintenance Phase - cinacalcet 03

Figure 4. Mean Serum Calcium (SE) at Baseline, End of Titration, and Scheduled Maintenance Visits (Patients with Severe intractable primary HPT) - cinacalcet 04

Figure 4. Mean Serum Calcium (SE) at Baseline, End of Titration, and Scheduled Maintenance Visits (Patients with Severe intractable primary HPT) - cinacalcet 04

PRINCIPAL DISPLAY PANEL - cinacalcet 30mg 30tab lab

PRINCIPAL DISPLAY PANEL - cinacalcet 30mg 30tab lab

This is a description of a medication called Cinacalcet with dosage information provided in the package insert. The tablets are coated and come in a package with NDC code 16729-440-10, with a dosage of 30mg per tablet. The medication is used for treatment of conditions relating to excessive parathyroid hormone. The tablets should be stored between 15°C to 30°C, (59°F to 86°F), and in a light-resistant container. The manufacturer of this medication is Accord Healthcare, Inc, located in Durham, NC 27703, and it is manufactured by Intas Pharmaceuticals Limited, based in Ahmedabad, India.*

PRINCIPAL DISPLAY PANEL - cinacalcet 60mg 30tab lab

PRINCIPAL DISPLAY PANEL - cinacalcet 60mg 30tab lab

Each film-coated tablet contains 60 mg of cinacalcet hydrochloride. The dosage information can be found in the package insert. The tablets should be stored at 25°C, with excursions permitted from 15°C to 30°C. They should be dispensed in a tight, light-resistant container as per USP. They are manufactured for Accord Healthcare Inc. in Durham, NC, and were made by Infas Pharmacicas Limed in Ahmedabad, India. A total of 30 tablets are included.*

PRINCIPAL DISPLAY PANEL - cinacalcet 90mg 30tab lab

PRINCIPAL DISPLAY PANEL - cinacalcet 90mg 30tab lab

Each film-coated tablet contains 90mg of cinacalcet hydrochloride, also known as cinacalcet NDC 16729-442-10. The dosage is available in the package insert, and the tablets should be stored at a temperature range of 15°C to 30°C (59°F to 86°F). The container should be light-resistant and tightly closed per USP regulations. Manufactured by Accord Healthcare, Inc. in Durham, NG 27703, and Infas Pharmaceuticals Limited, in Ahmedabad-382 210, India. This product is available by prescription only.*

The following structural formula for hydrochloride salt of cinacalcet is described chemically as N-[1-(R)-(-)-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride. - cinacalcet structure

The following structural formula for hydrochloride salt of cinacalcet is described chemically as N-[1-(R)-(-)-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride. - cinacalcet structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.